A study of AMG 416 in the treatment of secondary hyperparathyroidism in chronic kidney disease

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-004136-30

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To characterize the long-term safety and tolerability of AMG 416 in the treatment of SHPT in subjects with CKD on hemodialysis.


Critère d'inclusion

  • Secondary hyperparathyroidism in subjects with chronic kidney disease